FindTrial
Sign In

TheraBionic P1

DEVICE5 trials

Sponsors

Barbara Ann Karmanos Cancer Institute

Conditions

Advanced Breast CancerHER2-negative Breast CancerHepatocellular Carcinoma RecurrentHormone Receptor Positive TumorMetastatic Breast CancerMetastatic Colorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaTriple Negative Breast Cancer

Phase 2

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer
RecruitingNCT06576115
Barbara Ann Karmanos Cancer InstituteMetastatic Pancreatic Adenocarcinoma
Start: 2025-02-28End: 2027-07-01Target: 30Updated: 2026-08-10
Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
RecruitingNCT07130903
Barbara Ann Karmanos Cancer InstituteMetastatic Colorectal Adenocarcinoma
Start: 2025-09-10End: 2030-04-17Target: 102Updated: 2025-11-07

Unknown Phase

TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma
RecruitingNCT07118202
Barbara Ann Karmanos Cancer InstituteHepatocellular Carcinoma Recurrent
Start: 2025-10-20End: 2028-08-31Target: 198Updated: 2026-04-13
A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
RecruitingNCT07227831
Barbara Ann Karmanos Cancer InstituteAdvanced Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor +1
Start: 2026-01-16End: 2028-05-22Target: 82Updated: 2026-08-26
Study of the TheraBionic P1 Device in Patients With Metastatic Triple Negative Breast Cancer After Progression
Not yet recruitingNCT07672431
Barbara Ann Karmanos Cancer InstituteTriple Negative Breast Cancer
Start: 2026-09-01End: 2028-12-31Target: 24Updated: 2026-06-29